OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.
You can purchase shares of OncoCyte (NASDAQ:OCX) through any online brokerage.
Other companies in OncoCyte’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX) and Intensity Therapeutics (NASDAQ:INTS).
OncoCyte has a consensus price target of $3.35.
The stock price for OncoCyte (NASDAQ: OCX) is $2.95 last updated November 12, 2024 at 4:00 PM EST.
There are no upcoming dividends for OncoCyte.
OncoCyte’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for OncoCyte.
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.